Back to Directory
Avillion Life Sciences
Founded 2012
Clinical trial management and late-stage drug co-development
Avillion Life Sciences is a clinical development company providing trial management and drug co-development services to pharmaceutical and biotechnology partners. Its work focuses on late-stage studies designed to support regulatory submissions. Avillion’s partnership with Pfizer included the Phase III BFORE trial of bosutinib for chronic myeloid leukaemia. Founded in London in 2012, the business combines clinical development expertise with financing for selected partner programmes.